Top companies

ASIANPAINT - 2260.35 (-0.89%) AXISBANK - 970.2 (-1.81%) BAJAJFINSV - 1717 (-1.05%) BAJFINANCE - 7291.65 (-2%) BHARTIARTL - 1626.15 (-0.91%) BPCL - 280.2 (1.05%) COALINDIA - 381.55 (-1.42%) HDFCBANK - 1642.4 (-0.54%) HEROMOTOCO - 4024.8 (-1.64%) HINDUNILVR - 2340.5 (-0.2%) ICICIBANK - 1196.15 (-2.98%) INDUSINDBK - 960.45 (-1.06%) ITC - 437.55 (-0.03%) KOTAKBANK - 1893.3 (-1.42%) MARUTI - 11883.7 (-1.13%) ONGC - 265.8 (-1.32%) RELIANCE - 1273.7 (-2.43%) SBIN - 759.05 (-2.59%) TATAMOTORS - 760.75 (-1.76%) TATASTEEL - 129.7 (-1.49%) TCS - 4035.85 (-1.03%) TITAN - 3353.35 (-0.85%) WIPRO - 298.35 (-0.63%)
TRENDING #Dixon Technologies (India) Limited2 #BSE Limited2 #Nifty 502 #Oberoi Realty Limited1
Growmudra
Sector: Footwear

Bata India 


1288.85   -14 (-1.07%)

As on 21 Jan, 2025 17:57 IST
Open 1302.9
LTP 1288.85
Previous Close 1302.85
Day High 1313.2
Day Low 1285.1
Volume 116474

Peers

Company Name Price Change %Change Day High Day Low Prev.Close Volume
Mirza Intl  0 0 0 0 0 0 0
Relaxo Footwear  0 0 0 0 0 0 0
Liberty Shoes 0 0 0 0 0 0 0
Khadim India 0 0 0 0 0 0 0
Growmudra

Top Gainers

Company LTP Change Gain
BPCL 280.2 2.9 1.05 %
ITC 437.55 -0.15 -0.03 %
HINDUNILVR 2340.5 -4.7 -0.2 %
HDFCBANK 1642.4 -8.85 -0.54 %
WIPRO 298.35 -1.9 -0.63 %

Top Losers

Company LTP Change Loss
ICICIBANK 1196.15 -36.8 -36.8 %
SBIN 759.05 -20.2 -20.2 %
RELIANCE 1273.7 -31.75 -31.75 %
BAJFINANCE 7291.65 -148.45 -148.45 %
AXISBANK 970.2 -17.85 -17.85 %
Growmudra

Latest News


By Debdeep Gupta  |  21 Jan, 2025

Buy Dixon Technologies; target of Rs 20,500 : Motilal Oswal

Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...


By Debdeep Gupta  |  21 Jan, 2025

MCX shares plummet 10?ter Morgan Stanley issues 'underweight' call post-Q3 results

Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...


By Debdeep Gupta  |  21 Jan, 2025

Mankind Pharma shares fall 4% as Macquarie downgrades to 'underperform'

Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...


By Debdeep Gupta  |  21 Jan, 2025

Short Call | Are investors turning too picky for Q3 earnings season? Wipro, Bharat Dynamics in focus

The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...


By Debdeep Gupta  |  21 Jan, 2025

Sellwin Traders signs USD 3 mn MoU with UAE firm, posts 90% jump in Q3 income

Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...


Growmudra © 2025 all right reserved

Partner With Us